Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) : 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 72(2021), 1 vom: 23. Jan., Seite 1-8 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.04.2021 Date Revised 28.04.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciab049 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320459187 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320459187 | ||
| 003 | DE-627 | ||
| 005 | 20231225173628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciab049 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320459187 | ||
| 035 | |a (NLM)33483734 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lantos, Paul M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) |b 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2021 | ||
| 500 | |a Date Revised 28.04.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
| 520 | |a This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Rumbaugh, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Bockenstedt, Linda K |e verfasserin |4 aut | |
| 700 | 1 | |a Falck-Ytter, Yngve T |e verfasserin |4 aut | |
| 700 | 1 | |a Aguero-Rosenfeld, Maria E |e verfasserin |4 aut | |
| 700 | 1 | |a Auwaerter, Paul G |e verfasserin |4 aut | |
| 700 | 1 | |a Baldwin, Kelly |e verfasserin |4 aut | |
| 700 | 1 | |a Bannuru, Raveendhara R |e verfasserin |4 aut | |
| 700 | 1 | |a Belani, Kiran K |e verfasserin |4 aut | |
| 700 | 1 | |a Bowie, William R |e verfasserin |4 aut | |
| 700 | 1 | |a Branda, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Clifford, David B |e verfasserin |4 aut | |
| 700 | 1 | |a DiMario, Francis J |e verfasserin |4 aut | |
| 700 | 1 | |a Halperin, John J |e verfasserin |4 aut | |
| 700 | 1 | |a Krause, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Lavergne, Valery |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Matthew H |e verfasserin |4 aut | |
| 700 | 1 | |a Meissner, H Cody |e verfasserin |4 aut | |
| 700 | 1 | |a Nigrovic, Lise E |e verfasserin |4 aut | |
| 700 | 1 | |a Nocton, James Jay J |e verfasserin |4 aut | |
| 700 | 1 | |a Osani, Mikala C |e verfasserin |4 aut | |
| 700 | 1 | |a Pruitt, Amy A |e verfasserin |4 aut | |
| 700 | 1 | |a Rips, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenfeld, Lynda E |e verfasserin |4 aut | |
| 700 | 1 | |a Savoy, Margot L |e verfasserin |4 aut | |
| 700 | 1 | |a Sood, Sunil K |e verfasserin |4 aut | |
| 700 | 1 | |a Steere, Allen C |e verfasserin |4 aut | |
| 700 | 1 | |a Strle, Franc |e verfasserin |4 aut | |
| 700 | 1 | |a Sundel, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Tsao, Jean |e verfasserin |4 aut | |
| 700 | 1 | |a Vaysbrot, Elizaveta E |e verfasserin |4 aut | |
| 700 | 1 | |a Wormser, Gary P |e verfasserin |4 aut | |
| 700 | 1 | |a Zemel, Lawrence S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 72(2021), 1 vom: 23. Jan., Seite 1-8 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2021 |g number:1 |g day:23 |g month:01 |g pages:1-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciab049 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2021 |e 1 |b 23 |c 01 |h 1-8 | ||